Related Experiment Video
Updated: Dec 2, 2025

Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS
Published on: May 20, 2013
A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder
Dominika Olesova1, Jaroslav Galba2, Juraj Piestansky2
1Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9, 84510 Bratislava, Slovakia.
Insights
Researchers developed a new lab test to detect autism spectrum disorder (ASD) earlier using urine biomarkers. This method identifies specific metabolites linked to oxidative stress and gut bacteria, aiding in early diagnosis and treatment.
Area of Science:
- Biochemistry
- Neuroscience
- Analytical Chemistry
Background:
- Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with no established biomarkers.
- Current diagnostic methods rely on behavioral observation and clinical assessment, often leading to delayed diagnoses.
- Early diagnosis is crucial for timely intervention and improved outcomes in children with ASD.
Purpose of the Study:
- To develop a sensitive and reliable laboratory method for early detection of autism spectrum disorder.
- To identify and quantify potential urinary metabolomic biomarkers for ASD diagnosis and subtyping.
- To investigate disturbances in arginine and purine metabolism, and gut bacteria-associated metabolites in children with ASD.
Main Methods:
- Developed an ultra-high performance liquid chromatography-tandem triple quadrupole mass spectrometry (UHPLC-MS/MS) method for simultaneous analysis of six urinary metabolites.
- Utilized reversed-phase liquid chromatography with gradient elution on a Phenomenex Luna® Omega Polar C18 column.
- Analyzed urine samples from children with ASD and age-matched controls.
Main Results:
- The method successfully quantified methylguanidine, N-acetyl arginine, inosine, indole-3-acetic acid, indoxyl sulfate, and xanthurenic acid.
- Elevated levels of oxidative stress markers (methylguanidine, N-acetylarginine) and gut bacteria products (indoxyl sulfate, indole-3-acetic acid) were observed in children with ASD.
- The developed method demonstrated speed, sensitivity, and reliability for biomarker quantification.
Conclusions:
- The novel UHPLC-MS/MS method is well-suited for quantifying potential ASD biomarkers in urine.
- Metabolomic profiling reveals significant alterations in arginine and purine metabolism, and gut microbiota activity in children with ASD.
- This approach holds promise for earlier ASD detection and characterization.
Abstract:
Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed to the average age of four years or even more which adversely affects a child's perspective. A laboratory method allowing to detect the disorder at earlier stages is of a great need, as this could help the patients to start with treatment at a younger age, even prior to the clinical diagnosis. Recent evidence indicates that metabolomic markers should be considered as diagnostic markers, also serving for further differentiation and characterization of different subgroups of the autism spectrum. In this study, we developed an ultra-high performance liquid chromatography-tandem triple quadrupole mass spectrometry method for the simultaneous determination of six metabolites in human urine. These metabolites, namely methylguanidine, N-acetyl arginine, inosine, indole-3-acetic acid, indoxyl sulfate and xanthurenic acid were selected as potential biomarkers according to prior metabolomic studies. The analysis was carried out by means of reversed-phase liquid chromatography with gradient elution. Separation of the metabolites was performed on a Phenomenex Luna® Omega Polar C18 (100 × 1.0 mm, 1.6 µm) column at a flow rate of 0.15 mL/min with acetonitrile/water 0.1% formic acid aqueous as the mobile phase. The analysis was performed on a group of children with autism spectrum disorder and age-matched controls. In school children, we have detected disturbances in the levels of oxidative stress markers connected to arginine and purine metabolism, namely methylguanidine and N-acetylargine. Also, products of gut bacteria metabolism, namely indoxyl sulfate and indole-3-acetic acid, were found to be elevated in the patients' group. We can conclude that this newly developed method is fast, sensitive, reliable, and well suited for the quantification of proposed markers.
More Related Videos
07:34Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS
Published on: March 14, 2013
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019